title: Mutational analysis of N-ras, p53, CDKN2A (p16(INK4a)), p14(ARF), CDK4, and MC1R genes in human dysplastic melanocytic naevi.
authors.forename: T
authors.initials: T
authors.lastname: Papp
authors.forename: H
authors.initials: H
authors.lastname: Pemsel
authors.forename: I
authors.initials: I
authors.lastname: Rollwitz
authors.forename: H
authors.initials: H
authors.lastname: Schipper
authors.forename: D G
authors.initials: DG
authors.lastname: Weiss
authors.forename: D
authors.initials: D
authors.lastname: Schiffmann
authors.forename: R
authors.initials: R
authors.lastname: Zimmermann
mesh_terms: D000328:Adult; D014408:Biomarkers, Tumor / Q000235:genetics*; D051358:Cyclin-Dependent Kinase 4; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics; D018844:Cyclin-Dependent Kinases / Q000235:genetics; D004252:DNA Mutational Analysis; D004416:Dysplastic Nevus Syndrome / Q000235:genetics*; D005260:Female; D011905:Genes, ras / Q000235:genetics; D006801:Humans; D008297:Male; D008544:Melanocytes / Q000378:metabolism / Q000473:pathology*; D008875:Middle Aged; D009154:Mutation; D011518:Proto-Oncogene Proteins; D011979:Receptors, Pituitary Hormone / Q000235:genetics; D025803:Tumor Suppressor Protein p14ARF / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
chemical_list: D014408:Biomarkers, Tumor; D019941:Cyclin-Dependent Kinase Inhibitor p16; D011518:Proto-Oncogene Proteins; D011979:Receptors, Pituitary Hormone; D025803:Tumor Suppressor Protein p14ARF; D016159:Tumor Suppressor Protein p53; C029446:MSH receptor; C495900:CDK4 protein, human; D051358:Cyclin-Dependent Kinase 4; D018844:Cyclin-Dependent Kinases